Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 376-400 of 917 matching filings.

Per page
25
Current page
16
10-K/A File 001-31326

10-K/A

Filing date
19 Apr 2018
Reporting date
31 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31326

DEF 14A

Filing date
16 Apr 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-224207

S-3

Filing date
10 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2018
Reporting date
03 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
30 Mar 2018
Reporting date
26 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 001-31326

DEF 14C

Filing date
30 Mar 2018
Reporting date
30 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Mar 2018
Reporting date
26 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
19 Mar 2018
Reporting date
19 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
16 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-31326

8-K/A

Filing date
16 Mar 2018
Reporting date
26 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q/A File 001-31326

NT 10-Q/A

Filing date
08 Mar 2018
Reporting date
31 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K/A File 001-31326

NT 10-K/A

Filing date
08 Mar 2018
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-31326

8-K/A

Filing date
08 Mar 2018
Reporting date
19 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
05 Mar 2018
Reporting date
26 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
02 Mar 2018
Reporting date
26 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
23 Feb 2018
Reporting date
20 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Jan 2018
Reporting date
15 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .